In a study, participants took a one-time 5-gram dose of a liposomal ketone product
For the compounding pharmacy, this is not without legal risk
Using Ephedra alongside GLP-1 medications may heighten cardiovascular risks, making this combination unsafe
Recalls & Warnings September 24, 2020 FTC Sends Refund Checks to Consumers of Deceptive Joint Pain Supplement On September 24, 2020, the FTC announced it is mailing 4,782 checks totaling more than $76,000 to consumers who bought Isoprex, a supplement marketed with deceptive claims that it could treat or cure joint pain, muscle pain, headaches, and arthritis
503A vs 503B: Two Different Compounding Pathways The FDA's 2024 compounding decisions specifically targeted 503B outsourcing facilities
It reduces fraud, protects processors, and gives you a defensible trail if the order is disputed